Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

TRIDENT study- Studying diabetic nephropathy using precision medicine.


Collapse Overview 
Collapse abstract
TRIDENT, aims to develop ground-breaking therapeutics for patients living with diabetic kidney disease (or diabetic nephropathy) via the use of next generation multi-omics and precision medicine approaches.

TRIDENT is a collaborative network of expert physicians, basic scientists, clinical researchers, and renal pathologists from 16 North American medical centers and three pharmaceutical companies devoted to improving the lives of those affected by diabetic kidney disease.


Collapse Biography 

Collapse Time 
Collapse start date
2018-07-01

Collapse end date
2022-12-31